VVOS — Vivos Therapeutics Share News
0.000.00%
Last trade - 00:00- $4.80m
- $11.13m
- $17.44m
Brief: Vivos Therapeutics - Audit Reports For Fy2025 And Fy2024 Include Substantial Doubt About Going Concern
Brief: Vivos Therapeutics And South Palm Cardiovascular Associates Sign Definitive Agreements To Launch Regional Sleep Testing And Treatment Center
Vivos Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Vivos Therapeutics Q2 revenue rises 35% on service growth
Brief: Vivos Therapeutics Q2 Net Income USD -5.523 Million
Vivos Therapeutics Inc expected to post a loss of 39 cents a share - Earnings Preview
Vivos Therapeutics Q1 revenue jumps, driven by SCN acquisition
Brief: Vivos Therapeutics Q1 Net Income USD -7.751 Million
Brief: Recent Study Confirms Fundamental Correlation Between Severity Of Obstructive Sleep Apnea And Oral Anatomy
U.S. STOCKS ON THE MOVE-Netflix, FirstCash Holdings, CF Bankshares
U.S. STOCKS ON THE MOVE-OneSpaWorld, IMUNON, Cigna
Brief: Vivos Therapeutics And SoundHealth Collaborate To Expand Access To Groundbreaking FDA-Cleared Allergy And Sleep Technologies
Vivos jumps as device maker partners with SoundHealth to broaden sleep, allergy offerings
Vivos Therapeutics Q3 revenue rises, helped by SCN acquisition
Brief: Vivos Therapeutics Files For Non-Timely 10-Q With US SEC
Brief: Vivos Therapeutics Announces Landmark Clinical Trial Results In Pediatric Obstructive Sleep Apnea Treatment
Vivos Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Vivos Therapeutics Inc expected to post a loss of 38 cents a share - Earnings Preview
Brief: Vivos Therapeutics Inc - Vidasleep Oral Appliance Approved By CMS Pdac